Logo

Waters Announces $500M Stock Repurchase Program

Feb 18, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today announced that its board has approved a plan to repurchase up to $500 million of its outstanding common shares over the next 24 months.

The board gave its approval on Wednesday. Purchases will be made through open market transactions. The company recently completed a $500 million stock repurchase program that was announced in February 2009.

In early Friday trading on the New York Stock Exchange shares of Waters were up about 1 percent to $81.57.

Filed under

stock repurchase
Waters
Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.